SHANGHAI–(BUSINESS WIRE)–One of many quickest rising firms within the international robotic and digital surgical procedure house, Ronovo Surgical lately introduced profitable closing of latest financing to speed up its imaginative and prescient of broad, cross-specialty adoption of robotic-assisted surgical procedure (RAS). The most recent spherical of financing arms Ronovo with greater than $50M raised since 2020. Led by LongRiver Investments (LRI), this spherical garnered continued assist from present buyers – Lilly Asia Ventures, Vivo Capital, Matrix Companions China and GGV Capital – with CEC Capital performing as unique monetary advisor.
Exiting stealth mode, Ronovo unveils its inaugural robotic platform – Carina™, an modern modular system constructed on proprietary expertise to allow configurable robotic help for laparoscopic surgical procedures throughout a number of specialties. This spherical of oversubscribed financing will speed up the multi-discipline medical trial for Carina, strengthen R&D and medical purposes improvement, and additional bolster the corporate’s deeply skilled expertise base.
Developed in collaboration with famend Chinese language laparoscopic surgeons, Carina addresses quite a few ache factors in minimally invasive surgical procedures (MIS) with a modular and nimble robotic answer. The system supplies surgeons flexibility to select the most effective devices and probably the most preferrred anatomical entry primarily based on laparoscopy basis. On this means, surgeons can leverage – relatively than abandon – prior laparoscopic coaching and proceed to enhance upon their surgical efficiency, permitting for MIS in additional surgical specialties to be carried out robotically.
The modern modular structure of Carina minimizes gear footprint to maximize utilization of treasured OR house, thus changing into way more adaptable to typical OR environments in China. The surgical crew can select between 3-module or 4-module configuration relying on the anticipated complexity of the process, and the person modules are freely cell to be part of others as wanted in numerous ORs. Surgeons also can select from a full suite of devices to arm every module. In the end, the fluidity in configuration interprets to balancing medical functionality and procedural price, leading to improved usability for the surgical crew, greater utilization for the hospital, and diminished financial burden on the affected person.
Altogether, the differentiated medical capabilities and financial viability of the Carina system are poised to quickly speed up the adoption of robotic MIS usually surgical procedure, gynecology, thoracic surgical procedure, urology and different specialties. These specialties at the moment see almost 10 million MIS sufferers yearly in China, with 120,000 laparoscopic surgeons in over 10,000 hospitals.
“We are extremely grateful to our investors for their confidence in Ronovo’s strategy to democratize robotic surgery,” mentioned Dr. John Ma, Founder, Chairman and CEO of Ronovo. “From inception, we have stayed true to our belief that innovation must start from an original pursuit to solve actual unmet clinical needs.”
“Carina is designed with modular architecture to overcome the limited adoption of robotic MIS beyond urology,” mentioned Dr. Ying Mao, Co-Founder and CTO of Ronovo. “Thanks to the ingenuity and expertise of our talented team, we have achieved breakthrough in our core robotic technology for the Carina platform.”
“We are proud to have led this round of financing in Ronovo and its innovative modular robotic platform, which will be first-to-market in China,” commented Jiang Zhang, Founder and CEO of LRI “We are incredibly excited to partner with Ronovo to accelerate their product and clinical development, and we strongly believe in the clinical and commercial value of a modular robotic system as well as its viability for international adoption.”
Whereas Carina was developed with Chinese language laparoscopic surgeons because the use case, early discussions with robotic surgical procedure KOLs in US and Europe point out the system’s sturdy potential to overcome present obstacles of broad RAS adoptions in lots of worldwide markets. Ronovo plans to proceed discussions with medical KOLs, strategic companions and international buyers at upcoming conferences worldwide, together with the LSI Rising Medtech Summit, MedTech Strategist Innovation Summit, and Society of Robotic & Digital Surgical procedure.
About Ronovo Surgical
Based in 2019, Ronovo Surgical is accelerating the transition to actually clever MIS by means of modern robotic and digital options. It’s the solely delicate tissue robotic surgical procedure firm in China led by seasoned business leaders with experience in each business management and expertise improvement. Founder and CEO John Ma is former SVP at Intuitive and World Companion at Fosun Group. Co-Founder and CTO Ying Mao is former programs engineering lead at Auris Well being (now J&J Ethicon) and founding father of Dreamworld AR. With greater than twenty years of management expertise mixed particularly within the improvement and commercialization of surgical robotics programs, they now lead a seasoned core crew that represents deep product improvement and implementation experience in surgical robotics, industrial robotics, medical capital gear, and medical consumables from Chinese language and multinational producers. Moreover, Ronovo has vital international medical and technical sources, having established long-term partnerships with quite a few medical and technical advisors.
For extra data, please go to: http://www.ronovosurgical.com/.
About LongRiver Investments
Established in 2022, LongRiver Investments (LRI) focuses on VC funding within the healthcare and expertise sectors in Larger China, with the purpose of serving to startups develop by means of expanded enterprise connections and sharing long-term returns. Founder Jiang Zhang served in varied management roles at a world-leading built-in monetary group, together with founding Ping An Insurance coverage group’s VC/PE funding crew in 2012. For the previous decade, his crew raised a number of funds in USD and RMB, investing in additional than 40 healthcare and expertise firms around the globe – 16 of which listed on home and overseas exchanges. Having collaborated with quite a few well-reputed business companions, LRI endeavors to construct an business ecosystem, leverage international sources to drive industrial improvement, and domesticate the subsequent era of business leaders.
About CEC Capital
Based in 2000, CEC Capital is a number one funding financial institution in China with a core deal with TMT, shopper and healthcare sectors. Headquartered in Beijing with workplaces in Shanghai, Los Angeles and San Francisco, CEC supplies M&A, capital elevating and asset administration providers to purchasers in and out of doors of China.